Cryo-Cell IntlCCEL
13F holders, Q2 2024 (June 30)14holders
1new positions
1sold out
$7.61avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Cryo-Cell Intl Inc. (CCEL) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Hamilton Lane Advisors LLC ($3.1M), SFI Advisors, LLC ($1.3M) and Vanguard Group Inc. ($873K).
- Company
- Cryo-Cell Intl Inc.
- CUSIP
- 228895108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $433 |
| Exits | 1 | $216 |
All 13F filers, Q1 2024 → Q2 2024: 24,381 shares bought and 1,709 shares sold, net +22,672 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Hamilton Lane Advisors LLC | 2.52% | No change | 409,734 | $3.1M |
| SFI Advisors, LLC | 0.97% | No change | 165,300 | $1.3M |
| Vanguard Group Inc. | 0.00% | Add +23.5% | 114,779 | $873K |
| MassMutual Private Wealth & Trust, FSB | 0.03% | No change | 111,035 | $845K |
| Geode Capital Management, LLC | 0.00% | Add +10.4% | 23,657 | $180K |
| Northern Trust Corp. | 0.00% | Reduce -5.0% | 22,198 | $169K |
| Cerity Partners LLC | 0.00% | No change | 19,563 | $149K |
| Rowlandmiller & Partners.adv | 0.02% | No change | 14,433 | $110K |
| BlackRock Inc. | 0.00% | Add +1.6% | 13,141 | $100K |
| Osaic Holdings, Inc. | 0.00% | Reduce -20.0% | 2,000 | $15K |
| Morgan Stanley | 0.00% | Add +0.2% | 601 | $5K |
| Royal Bank of Canada | 0.00% | Add +63.5% | 121 | $1K |
| Bank of America Corp. | 0.00% | New | 57 | $433 |
| JPMorgan Chase & Co. | 0.00% | No change | 11 | $84 |
"% of holder's portfolio" is CCEL's weight in each manager's 13F, not the share of Cryo-Cell Intl Inc. the manager owns.